Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAEMC.L Regulatory News (AEMC)

  • There is currently no data for AEMC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement re dealings in shares

6 Jan 2020 07:00

RNS Number : 7502Y
Aberdeen Emerging Markets Inv Co Ld
06 January 2020
 

 

ABERDEEN EMERGING MARKETS INVESTMENT COMPANY LIMITED ("the Company")

 

Legal Entity Identifier (LEI): 213800RIA1NX8DP4P938

 

6 January 2020

 

Aberdeen Emerging Markets Investment Company Limited announces that it is satisfied that any inside information which the Directors or the Company may have had up to today's date has previously been notified to a Regulated Information Service ("RIS").

 

By virtue of the points set out in (1) to (4) below, the Directors and the Company do not currently expect there to be any inside information arising in the closed period as defined by the EU Market Abuse Regulation. The closed period will end on the date of the announcement of the Company's Annual Financial Report for the year ended 31 October 2019.

 

1) the announcement on 1 November 2019 of the Company's net asset value per share as of the close of business on 31 October 2019,

2) the Company's belief, following reasonable enquiries, that there will be no material difference between the information published on 1 November 2019 and that to be included in the forthcoming announcement of the Annual Financial Report,

3) the Company's practice of calculating net asset values per share each business day and the announcement of these net asset values to an RIS, and

4) there being no other unpublished information which constitutes price-sensitive information in respect of the Company's securities.

 

The Company is therefore not prohibited from dealing in its own securities during the closed period.

 

If, during the closed period leading up to the announcement of the Annual Financial Report, the Company or its Directors become aware of any inside information, such inside information will be managed in accordance with the UKLA's DTR 2.

 

Enquiries:

 

Aberdeen Standard Fund Managers Limited (Alternative Investment Fund Manager to Aberdeen Emerging Markets Investment Company Limited)

 

William Hemmings

Tel: +44 (0)207 463 6223

 

Luke Mason

Tel +44 (0)207 463 5971

 

Andrew Lister / Bernard Moody

Tel: +44 (0)20 7618 1440

 

PraxisIFM Fund Services (UK) Limited (UK Administration Agent)

Sylvanus Cofie Tel: +44 (0)20 7653 9690

 

Ordinary Shares - Listing Category: Premium - Equity Closed-ended Investment Funds

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STRUOOBRRSUARAR
Date   Source Headline
22nd Mar 20212:10 pmRNSNet Asset Value(s)
19th Mar 20214:24 pmRNSNet Asset Value(s)
18th Mar 20211:40 pmRNSNet Asset Value(s)
17th Mar 20211:47 pmRNSNet Asset Value(s)
16th Mar 20211:19 pmRNSNet Asset Value(s)
15th Mar 20211:45 pmRNSNet Gearing Ratio
15th Mar 20211:43 pmRNSNet Asset Value(s)
12th Mar 20213:00 pmRNSNet Asset Value(s)
12th Mar 202112:20 pmRNSAvailability of Portfolio Data on Website
11th Mar 20212:00 pmRNSNet Asset Value(s)
10th Mar 20211:01 pmRNSNet Asset Value(s)
9th Mar 20212:11 pmRNSNet Asset Value(s)
8th Mar 202112:35 pmRNSNet Gearing Ratio
8th Mar 202112:34 pmRNSNet Asset Value(s)
5th Mar 20213:06 pmRNSNet Asset Value(s)
4th Mar 20212:17 pmRNSNet Asset Value(s)
3rd Mar 20212:34 pmRNSNet Asset Value(s)
2nd Mar 20212:20 pmRNSNet Asset Value(s)
1st Mar 20212:05 pmRNSNet Gearing Ratio
1st Mar 20212:00 pmRNSNet Asset Value(s)
26th Feb 20213:30 pmRNSNet Asset Value(s)
25th Feb 202112:35 pmRNSNet Asset Value(s)
24th Feb 20211:59 pmRNSNet Asset Value(s)
23rd Feb 20211:00 pmRNSNet Asset Value(s)
22nd Feb 20212:05 pmRNSNet Gearing Ratio
22nd Feb 20212:00 pmRNSNet Asset Value(s)
19th Feb 202111:51 amRNSNet Asset Value(s)
18th Feb 20214:50 pmRNSDividend Declaration
18th Feb 20214:47 pmRNSFinal Results
18th Feb 20211:29 pmRNSNet Asset Value(s)
17th Feb 20211:27 pmRNSNet Asset Value(s)
16th Feb 20211:20 pmRNSNet Asset Value(s)
15th Feb 20211:05 pmRNSNet Gearing Ratio
15th Feb 20211:00 pmRNSNet Asset Value(s)
12th Feb 20211:34 pmRNSNet Asset Value(s)
12th Feb 202110:34 amRNSPortfolio Update
11th Feb 20212:32 pmRNSNet Asset Value(s)
10th Feb 20211:26 pmRNSNet Asset Value(s)
9th Feb 20212:03 pmRNSNet Asset Value(s)
8th Feb 20212:30 pmRNSNet Gearing Ratio
8th Feb 20212:15 pmRNSNet Asset Value(s)
5th Feb 20213:30 pmRNSNet Asset Value(s)
4th Feb 20213:02 pmRNSNet Asset Value(s)
3rd Feb 20212:26 pmRNSNet Asset Value(s)
2nd Feb 20211:52 pmRNSNet Asset Value(s)
1st Feb 20213:40 pmRNSNet Gearing Ratio
1st Feb 20213:35 pmRNSNet Asset Value(s)
29th Jan 20211:45 pmRNSNet Asset Value(s)
28th Jan 20211:36 pmRNSNet Asset Value(s)
27th Jan 20211:54 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.